ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Treatment review for male pattern hair-loss
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 172253" data-attributes="member: 13851"><p><strong><span style="color: rgb(184, 49, 47)">ABSTRACT</span> </strong></p><p></p><p><span style="color: rgb(0, 0, 0)"><strong>Introduction:</strong> </span><em>Androgenetic alopecia is a common hair loss disorder affecting up to 80% of males by the age of 80. It is characterized by androgen-related progressive thinning of hair in a defined pattern. It results in diminished self-esteem, reduced confidence, and distress in affected men, irrespective of age or stage of baldness. Effective treatment for hair baldness is needed.</em></p><p></p><p><strong>Areas covered: </strong><em>In androgenetic alopecia, hair follicles undergo progressive miniaturization. Genetic factors and androgens are key role players in disease pathogenesis. Herein the authors review the pharmacologic treatment of androgenetic alopecia, which involves 5 alpha-reductase inhibitors, minoxidil, and prostaglandins. Non-pharmacologic approaches are also explored.</em></p><p></p><p><strong>Expert opinion:</strong><em> Androgenetic alopecia progresses over time and although the currently available medical treatments like finasteride and minoxidil are effective in arresting the progression of the disease, they allow only partial regrowth of hair at its best. Early treatment achieves a more optimal outcome. Non-pharmacologic treatments like PRP can be considered in patients refractory to medical treatment.</em></p><p></p><p></p><p></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">5. </span>Conclusion </strong></p><p><strong></strong></p><p><strong><span style="color: rgb(184, 49, 47)"><em>Patients with MPHL can have varied responses to treatment.</em></span><em> <span style="color: rgb(184, 49, 47)">Oral finasteride and topical minoxidil are both FDA-approved for the treatment of MPHL and have been the mainstay of treatment to date.</span></em></strong><em> <span style="color: rgb(44, 130, 201)"><strong>However, significant developments in hair research have resulted in a number of new pharmacotherapeutic and procedural treatments for hair growth promotion.</strong></span> <span style="color: rgb(26, 188, 156)"><strong>Actively recruiting clinical trials aims to explore novel treatments in AGA. Single-agent treatment may not be sufficient to produce the desired outcome long-term. </strong></span></em><span style="color: rgb(147, 101, 184)"><strong><em>Overall, combination therapy incorporating systemic pharmacotherapy with procedural modalities may be the way to produce sustainable results.</em></strong></span></p></blockquote><p></p>
[QUOTE="madman, post: 172253, member: 13851"] [B][COLOR=rgb(184, 49, 47)]ABSTRACT[/COLOR] [/B] [COLOR=rgb(0, 0, 0)][B]Introduction:[/B][I] [/I][/COLOR][I]Androgenetic alopecia is a common hair loss disorder affecting up to 80% of males by the age of 80. It is characterized by androgen-related progressive thinning of hair in a defined pattern. It results in diminished self-esteem, reduced confidence, and distress in affected men, irrespective of age or stage of baldness. Effective treatment for hair baldness is needed.[/I] [B]Areas covered: [/B][I]In androgenetic alopecia, hair follicles undergo progressive miniaturization. Genetic factors and androgens are key role players in disease pathogenesis. Herein the authors review the pharmacologic treatment of androgenetic alopecia, which involves 5 alpha-reductase inhibitors, minoxidil, and prostaglandins. Non-pharmacologic approaches are also explored.[/I] [B]Expert opinion:[/B][I] Androgenetic alopecia progresses over time and although the currently available medical treatments like finasteride and minoxidil are effective in arresting the progression of the disease, they allow only partial regrowth of hair at its best. Early treatment achieves a more optimal outcome. Non-pharmacologic treatments like PRP can be considered in patients refractory to medical treatment.[/I] [B][COLOR=rgb(184, 49, 47)]5. [/COLOR]Conclusion [COLOR=rgb(184, 49, 47)][I]Patients with MPHL can have varied responses to treatment.[/I][/COLOR][I] [COLOR=rgb(184, 49, 47)]Oral finasteride and topical minoxidil are both FDA-approved for the treatment of MPHL and have been the mainstay of treatment to date.[/COLOR][/I][/B][I] [COLOR=rgb(44, 130, 201)][B]However, significant developments in hair research have resulted in a number of new pharmacotherapeutic and procedural treatments for hair growth promotion.[/B][/COLOR] [COLOR=rgb(26, 188, 156)][B]Actively recruiting clinical trials aims to explore novel treatments in AGA. Single-agent treatment may not be sufficient to produce the desired outcome long-term. [/B][/COLOR][/I][COLOR=rgb(147, 101, 184)][B][I]Overall, combination therapy incorporating systemic pharmacotherapy with procedural modalities may be the way to produce sustainable results.[/I][/B][/COLOR] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Treatment review for male pattern hair-loss
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top